Abstract

No AccessJournal of UrologyEditorial1 Mar 2014Percutaneous Tibial Nerve Stimulation for Refractory Lower Urinary Tract Symptoms in Patients with Neurogenic Bladder Conditions Gary E. Lemack Gary E. LemackGary E. Lemack Financial interest and/or other relationship with Afferent Pharmaceuticals, Ferring, Merck, Pfizer, Astellas and Allergan. More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2013.12.024AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Percutaneous Tibial Nerve Stimulation for Refractory Lower Urinary Tract Symptoms in Patients with Neurogenic Bladder Conditions." The Journal of Urology, 191(3), pp. 582–583 References 1 : Maintenance percutaneous posterior nerve stimulation for refractory lower urinary tract symptoms in patients with multiple sclerosis: an open label, multicenter, prospective study. J Urol2014; 191: 697. Link, Google Scholar 2 : Treatment of motor and sensory detrusor instability by electrical stimulation. J Urol1983; 129: 78. Link, Google Scholar 3 : Afferent nerve stimulation for pelvic floor dysfunction. Eur Urol1999; 35: 16. Google Scholar 4 : Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol2010; 183: 234. Link, Google Scholar 5 : Posterior tibial nerve stimulation in the treatment of voiding dysfunction: urodynamic data. Neurourol Urodyn2004; 23: 246. Google Scholar 6 : Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson's disease. Neurourol Urodyn2009; 28: 62. Google Scholar 7 : The clinical and urodynamic results of a 3-month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis-related neurogenic bladder dysfunction. Neurourol Urodyn2009; 28: 964. Google Scholar 8 : Acute urodynamic effects of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with MS. Eur Urol2007; 51: 464. Google Scholar 9 : Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial. Mult Scler2011; 17: 1514. Google Scholar 10 : Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: results of a multicenter prospective study. Neurourol Urodyn2011; 30: 306. Google Scholar 11 : Characteristics of persons with overactive bladder of presumed neurologic origin: results from the Boston Area Community Health (BACH) Survey. Neurourol Urodyn2012; 31: 1149. Google Scholar © 2014 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 191Issue 3March 2014Page: 582-583 Advertisement Copyright & Permissions© 2014 by American Urological Association Education and Research, Inc.MetricsAuthor Information Gary E. Lemack Financial interest and/or other relationship with Afferent Pharmaceuticals, Ferring, Merck, Pfizer, Astellas and Allergan. More articles by this author Expand All Advertisement PDF downloadLoading ...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call